Register for LSI Europe '27 Today

News

Join LSI Europe '27

CEO and Co Founder Aidan Crawley discusses Amber Therapeutics Series A raise at LSI Europe 2024

Amber Therapeutics’ Series A: Behind the $100M Raise

Amber Therapeutics’ Series A wasn’t just a headline—it was a milestone. In one of the lar...

Christina Vallgren and Marta Zanchi discuss navigating the highs lows and long haul dynamics of the investor founder relationship at LSI Europe 2024

Investor-Founder Partnerships: “Value-Add” Is a Two-Way Street

Medtech partnerships built on capital alone rarely go the distance. The most successful companies are often...

Panelists discuss medtech portfolio optimization at LSI Europe 2024

Medtech Portfolio Optimization: Why Investors Say No (and What That Really Means)

panelists discuss consumerization of healthcare at LSI europe 2024

Consumerization of Healthcare: Understanding Patient Behavior

panelists discuss how to forge successful medtech partnerships with strategics at LSI europe 2024

Forging Successful Medtech Partnerships with Strategics

Panelists discuss the advent of sensor rich connected medical devices at LSI Europe 2024

Connected Medical Devices: AI, Data, and the Future of Healthcare

Panelists discuss the shift to alternate care sites at LSI Europe 2024

Alternate Care Sites: A Shift Transforming Patient Care

Panelists discuss the role of AI in surgery and Caresyntax’s recent $180 million Series C funding round at LSI Europe 2024

AI in Surgery: How Caresyntax is Transforming the OR with $180M

Panelists discuss how to navigate the complexities of technology transfer in medtech at LSI Europe 2024

Technology Transfer in Medtech: The Path to Successful Investments

Panelists discuss strategies for achieving successful U.S. market access at LSI Europe 2024

Navigating U.S. Market Access as an International Medtech Company

Panelists discuss maternal healthcare disparities and how to bridge the gap at LSI Europe 2024

Addressing Maternal Healthcare Disparities: Insights from LSI Europe ’24

Duke Rohlen presents his growth driver framework for developing high growth medtech products within slow growth companies

The Growth Driver Framework: Insights from Duke Rohlen

‹
1
2
3
4
›